Things are never simple | Vitamin Supplement providers, manufactures of "performance enhancing" drugs and Marijuana growers are excoriated and prosecuted with vigor by the Feds | Not that there aren't risks with unknown elements | But the Big Pharma Industry has generally been treated with kid gloves and tender loving care by the same politicians | Be it the no-hands approach to scadalous prescription drug costs, or a see-no-evil attitude about adverse reactions and dangers to drugs being legally pushed | Is it any wonder that mental patients complain of being guinea pigs? [rhetorical question on my part] Some of the latest stuff in the headlines |

``Balco is now a household word, and, thanks to misinformation contained in the many leaks, it is a word as loaded as a hand grenade,'' the lawyers for Victor Conte Jr. and James Valente, Balco's president and vice president, respectively, wrote in an informational motion submitted Friday.
``It is now very doubtful that these defendants can ever receive a fair trial -- anywhere.''
The political allegations are being leveled by J. Tony Serra, Anderson's attorney, who in April filed a motion suggesting that the case was powered by political motivations and was ultimately intended to help get President Bush re-elected.
Serra had asked the judge to allow him to get an internal memorandum from the government that could show the case being orchestrated from the White House | Serra said the goal of eliminating performance-enhancing drugs from athletics was ``laudable,'' but that unless the judge orders the prosecution to produce the memorandums, ``We will forever believe that we are being sacrificed for the greater good of the establishment, and that's not right.''
Prosecutor Jeff Nedrow argued that Serra had no evidence to support his charge.
There's more... †

"Merck has long been committed to publishing the results of all of our trials in a timely manner," said Dr. Peter Honig, a senior vice president, "and now we're strengthening that commitment." One reason for the new postings, Dr. Honig said, is the industry's growing image problem |
"Let's face it, the perceptions of the pharmaceutical industry as a whole are not healthy at the moment," he said |
There's more... †

Pfizer's warning letter to doctors said "few reports" of hyperglycemia or diabetes were noted in patients prescribed Geodon. But it also noted fewer patients were treated with that particular antipsychotic | As a whole, so-called atypical antipsychotic drugs were linked to such adverse events as diabetes and high blood sugar - in some cases, extreme enough to induce coma or death | Geodon, approved to treat schizophrenia, on Aug. 23 gained FDA approval for the treatment of acute bipolar mania |
FOOTNOTES † Means you'll have to subscribe to the publication's online story service | Right now, both sources noted above are free | for the NY Times, try entering "gorevidal" into the member and password line | THANKS TO: Stefan Kruszewski
0 Comments:
Post a Comment
<< Home